ROXICODONE Drug Patent Profile
✉ Email this page to a colleague
When do Roxicodone patents expire, and what generic alternatives are available?
Roxicodone is a drug marketed by Roxane and Specgx Llc and is included in two NDAs.
The generic ingredient in ROXICODONE is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Roxicodone
A generic version of ROXICODONE was approved as oxycodone hydrochloride by SPECGX LLC on June 30th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROXICODONE?
- What are the global sales for ROXICODONE?
- What is Average Wholesale Price for ROXICODONE?
Summary for ROXICODONE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 16 |
Patent Applications: | 2,337 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ROXICODONE |
What excipients (inactive ingredients) are in ROXICODONE? | ROXICODONE excipients list |
DailyMed Link: | ROXICODONE at DailyMed |
![ROXICODONE drug patent expirations Drug patent expirations by year for ROXICODONE](/p/graph/s/t/ROXICODONE-patent-expirations.png)
![Drug Prices for ROXICODONE](/p/graph/drug-price/ROXICODONE.png)
Recent Clinical Trials for ROXICODONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Miami | Phase 2 |
West Virginia Clinical and Translational Science Institute | Phase 4 |
West Virginia University | Phase 4 |
Pharmacology for ROXICODONE
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for ROXICODONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roxane | ROXICODONE | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020932-001 | Oct 26, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | ROXICODONE | oxycodone hydrochloride | TABLET;ORAL | 021011-001 | Aug 31, 2000 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Roxane | ROXICODONE | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020932-002 | Oct 26, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | ROXICODONE | oxycodone hydrochloride | TABLET;ORAL | 021011-003 | May 15, 2009 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Specgx Llc | ROXICODONE | oxycodone hydrochloride | TABLET;ORAL | 021011-002 | Aug 31, 2000 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |